Research paperPreclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effects
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; (S)-3,4-DCPG; (S)-3,4-dicarboxyphenylglycine; LY341495; (2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid; mGlu; metabotropic glutamate; LY354740.H2O; bicyclo[3.1.0]